The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-tritylimidazolidin-2-one ID: ALA3330916
PubChem CID: 118713313
Max Phase: Preclinical
Molecular Formula: C22H20N2O
Molecular Weight: 328.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NCCN1C(c1ccccc1)(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C22H20N2O/c25-21-23-16-17-24(21)22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-15H,16-17H2,(H,23,25)
Standard InChI Key: WYVPRGBNBZNIEM-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
5.8862 -19.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5898 -19.6826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2935 -19.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2947 -18.4641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5864 -18.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8856 -18.4646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4771 -19.9848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0643 -20.6884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4672 -21.3957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2828 -21.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6937 -20.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2885 -19.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2809 -18.4815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9857 -18.0706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9813 -17.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2729 -16.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5674 -17.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5752 -18.0810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9789 -18.8460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9789 -19.6631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7548 -19.9314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2584 -19.2752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7548 -18.6148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0714 -19.2752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0231 -20.7073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
22 24 1 0
21 25 2 0
24 7 1 0
24 13 1 0
24 1 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 328.42Molecular Weight (Monoisotopic): 328.1576AlogP: 4.00#Rotatable Bonds: 4Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 1HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.29CX LogD: 4.29Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -0.36
References 1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B.. (2014) Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity., 86 [PMID:25203780 ] [10.1016/j.ejmech.2014.09.013 ]